Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $13.00 price target on the stock ...

NASH is associated with overnutrition ... and mild/moderate portal chronic inflammation. On high magnification (×400, insert), hepatocellular ballooning (black arrow) and a focus of mixed ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, Hess Midstream, ASML Holding and Ares Capital, among others.

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver ... the NAFLD-induced inflammation and improving ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the breakthrough Phase 2b SYMMETRY data.

Research in biologic therapies is rapidly advancing, particularly for moderate to severe cases of NAFLD involving chronic inflammation ... in the treatment of NAFLD and NASH. It helps improve liver ...

Along with NASH, Novo Nordisk is also planning to investigate the drug's activity in chronic kidney disease ... liver fibrosis, gout, inflammatory bowel disease, and cardiovascular diseases ...

The biotech thinks they can reduce the damage caused by chronic, uncontrolled inflammation ... non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and osteoarthritis.

Interestingly, one study showed that chronic administration of oral galanin once ... This study showed that galanin caused a significant improvement in NASH features, including liver inflammation and ...

The three main causes of inflammation and chronic injury in the liver are viral hepatitis ... inferring a protective role during NASH progression (105). Regarding these Th cell populations, Rolla et ...